https://scholars.lib.ntu.edu.tw/handle/123456789/504591
標題: | Psychometric and Clinimetric Properties of the Melbourne Assessment 2 in Children With Cerebral Palsy | 作者: | TIEN-NI WANG Liang K.-J. Liu Y.-C. JENG-YI SHIEH HAO-LING CHEN |
公開日期: | 2017 | 出版社: | W.B. Saunders | 卷: | 98 | 期: | 9 | 起(迄)頁: | 1836-1841 | 來源出版物: | Archives of Physical Medicine and Rehabilitation | 摘要: | Objective To examine the psychometric and clinimetric properties of the Melbourne Assessment 2 (MA2), an outcome measurement that is increasingly used in clinical studies. Design Psychometric and clinimetric study. Setting Community. Participants Seventeen children with cerebral palsy (CP) from 5 to 12 years were recruited for the estimation of the test-retest reliability and minimal detectable change (MDC). Thirty-five children with CP were recruited to receive an 8-week intensive neurorehabilitation intervention to estimate the validity, responsiveness, and minimal clinically important difference (MCID). Interventions Thirty-five children with CP received upper limb neurorehabilitation programs for 8 weeks. Main Outcome Measures The MA2 and the criterion measures, including the Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), the Box and Blocks Test (BBT), and the Pediatric Motor Activity Log–Revised (PMAL-R), were evaluated at pretreatment and posttreatment. Results The MA2 has 4 subscales: range of motion, fluency, accuracy, and dexterity. The test-retest reliability of the MA2 is high (intraclass correlation coefficient,.92–.98). The significant relationships between the MA2 and BBT, BOT-2, and PMAL-R support its validity. The significance of paired t test results (P<.001) and large magnitudes of the standardized response mean (1.70–2.00) confirm the responsiveness of the MA2. The MDC values of the 4 subscales of the MA2 are 2.85, 1.63, 1.97, and 1.84, respectively, and the suggested MCID values of these 4 subscales are 2.35, 3.20, 2.09, and 2.22, respectively, indicating the minimum scores of improvement to be interpreted as both statistically significant and clinically important. Conclusions The study findings indicate that the MA2 has sound psychometric and clinimetric properties and is thus an adequate measurement for research and clinical applications. ? 2017 American Congress of Rehabilitation Medicine |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018626207&doi=10.1016%2fj.apmr.2017.01.024&partnerID=40&md5=858f8f0bffbb3a8a0a9afc823418cdbb https://scholars.lib.ntu.edu.tw/handle/123456789/504591 |
ISSN: | 0003-9993 | DOI: | 10.1016/j.apmr.2017.01.024 | SDG/關鍵字: | accuracy; Article; Bruininks-Oseretsky test of motor proficiency; cerebral palsy; child; clinical article; concurrent validity; dexterity test; female; finger; hemiplegia; human; male; Melbourne Assessment 2; minimal clinically important difference; motor activity; motor performance; neurologic disease assessment; neurorehabilitation; outcome assessment; psychometry; quadriplegia; range of motion; test retest reliability; upper limb; cerebral palsy; disability; minimal clinically important difference; neurorehabilitation; preschool child; procedures; psychology; psychometry; reproducibility; statistics and numerical data; treatment outcome; validation study; Victoria; Cerebral Palsy; Child; Child, Preschool; Disability Evaluation; Female; Humans; Male; Minimal Clinically Important Difference; Neurological Rehabilitation; Psychometrics; Reproducibility of Results; Treatment Outcome; Upper Extremity; Victoria |
顯示於: | 職能治療學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。